FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma
The drug company voluntarily requested the withdrawal of infigratinib, citing challenges enrolling patients for the required confirmatory postmarketing trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 21, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer
(MedPage Today) -- The FDA has withdrawn the approval of infigratinib (Truseltiq) as a second-line treatment for metastatic cholangiocarcinoma at the request of the drugmaker, the agency announced on Friday. Infigratinib, a fibroblast growth factor... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 20, 2024 Category: American Health Source Type: news

WITHDRAWN: FDA grants accelerated approval to infigratinib for metastatic cholangiocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 17, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Little known warning signs of bile duct cancer after death of Game of Thrones star Ian Gelder
Game of Thrones star Ian Gelder has died age 74 following a five month battle with bile duct cancer. In England, around 2,800 people are diagnosed with bile duct cancer a year. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2024 Category: Consumer Health News Source Type: news

'I have barely 2% chance of living but I'm determined to beat this cancer'
28 year old doctor Gareth Honeybone reveals why he's still laughing despite his diagnosis of deadly bile duct cancer (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2024 Category: Consumer Health News Source Type: news

'I'm a 28 year old doctor - I didn't realise I had rare cancer until I took a blood test'
28 year old doctor Gareth Honeybone reveals why he's still laughing despite his diagnosis of deadly bile duct cancer (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2024 Category: Consumer Health News Source Type: news

'As a doctor I take cancer seriously - but this is why I'm laughing at my own'
28-year-old doctor Gareth Honeybone tells Adrian Monti why he's still laughing despite his diagnosis of deadly bile duct cancer (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2024 Category: Consumer Health News Source Type: news

CEUS adds to locoregional therapy for liver disease
Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver, according to early study results presented April 10 at UltraCon. In her presentation, PhD candidate Corinne Wessner from Thomas Jefferson University in Philadelphia, PA, highlighted initial findings from her team’s ongoing work suggesting that microbubble destruction from CEUS triggering is safe and well-tolerated among patients with intrahepatic cholangiocarcinoma (ICC) and metastatic liver disease who also receive transarterial radioembolization with yttrium-90 (Y90-TARE). “When we add the ultrasound-t...
Source: AuntMinnie.com Headlines - April 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news

Hepatic Infusion Pumps: New Enthusiasm for an Old Technology Hepatic Infusion Pumps: New Enthusiasm for an Old Technology
Patients with advanced, unresectable cholangiocarcinoma had significantly better survival outcomes after treatment with hepatic arterial chemotherapy infusion pumps vs standard therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 23, 2024 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news

HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma
(MedPage Today) -- SAN FRANCISCO -- Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), according to results from a... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 21, 2024 Category: Gastroenterology Source Type: news

Hospice nurse shares three common symptoms of bile duct cancer - ‘go to the doctor’
Many people don't go to the doctor for these symptoms because they're "general and generic". (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2024 Category: Consumer Health News Source Type: news

Research fuels advances in bile duct cancer care
Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often diagnosed in later stages, making it more difficult to treat, and cases in the U.S. are increasing. In a review article published in Nature Reviews Clinical Oncology in 2023, lead author Sumera I. Ilyas, M.B.B.S., and co-authors share advances in diagnosing, staging and treating bile duct cancer. Dr.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 13, 2024 Category: Databases & Libraries Source Type: news

Mark Shelmerdine, BAFTA L.A. Co-Founder and Producer Who Revived London Films, Dies at 78
Mark Shelmerdine, the BAFTA L.A. co-founder and producer who is credited with reviving Alexandra Korda’s London Films, died Oct. 26 in Santa Barbara after a long illness. He was 78. Shelmerdine was diagnosed with a rare form of bile duct cancer in 2016. After being treated in a trial program…#markshelmerdine #baftala #alexandrakordas #londonfilms #santabarbara #shelmerdine #houston #taylorclark #robertclark #abccinema (Source: Reuters: Health)
Source: Reuters: Health - December 2, 2023 Category: Consumer Health News Source Type: news

Drug Trials Snapshot: LYTGOBI
LYTGOBI is a drug used for the treatment of adults with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that has spread to other parts of the body (metastatic) or cannot not be removed by surgery (unresectable). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Consumer Health: Liver cancer --  risk factors and prevention
October is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you can do to prevent it. More than 41,000 new cases of primary liver cancer and intrahepatic bile duct cancer will be diagnosed in the U.S. this year, and nearly 30,000 people will die of these diseases, according to the American Cancer Society. Liver cancer is cancer that begins in the cells of your liver, which… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 12, 2023 Category: Databases & Libraries Source Type: news